Metabolic heterogeneity protects metastatic mucosal melanomas cells from ferroptosis
- Authors:
- Weifan Lin
- Xiangwan Lu
- Hang Yang
- Linxuan Huang
- Wuheng Huang
- Yuluan Tang
- Situn Liu
- Hua Wang
- Yan Zhang
-
Affiliations: MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat‑sen University, Guangzhou, Guangdong 510006, P.R. China, Department of Oral and Maxillofacial Surgery, Guanghua School of Stomatology, Guanghua Hospital of Stomatology, Sun Yat‑sen University, Guangzhou, Guangdong 510055, P.R. China - Published online on: August 16, 2022 https://doi.org/10.3892/ijmm.2022.5180
- Article Number: 124
-
Copyright: © Lin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Spencer KR and Mehnert JM: Mucosal melanoma: Epidemiology, biology and treatment. Cancer Treat Res. 167:295–320. 2016. View Article : Google Scholar | |
Nassar KW and Tan AC: The mutational landscape of mucosal melanoma. Semin Cancer Biol. 61:139–148. 2020. View Article : Google Scholar : | |
Merkel EA and Gerami P: Malignant melanoma of sun-protected sites: A review of clinical, histological, and molecular features. Lab Invest. 97:630–635. 2017. View Article : Google Scholar : PubMed/NCBI | |
Ascierto PA, Accorona R, Botti G, Farina D, Fossati P, Gatta G, Gogas H, Lombardi D, Maroldi R, Nicolai P, et al: Mucosal melanoma of the head and neck. Crit Rev Oncol Hematol. 112:136–152. 2017. View Article : Google Scholar : PubMed/NCBI | |
Davis LE, Shalin SC and Tackett AJ: Current state of melanoma diagnosis and treatment. Cancer Biol Ther. 20:1366–1379. 2019. View Article : Google Scholar : PubMed/NCBI | |
Yde SS, Sjoegren P, Heje M and Stolle LB: Mucosal melanoma: A literature review. Curr Oncol Rep. 20:282018. View Article : Google Scholar : PubMed/NCBI | |
Poh A: First oncolytic viral therapy for melanoma. Cancer Discov. 6:62016. View Article : Google Scholar | |
Killock D: Skin cancer: T-VEC oncolytic viral therapy shows promise in melanoma. Nat Rev Clin Oncol. 12:4382015. View Article : Google Scholar : PubMed/NCBI | |
Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr and Kinzler KW: Cancer genome landscapes. Science. 339:1546–1558. 2013. View Article : Google Scholar : PubMed/NCBI | |
Chambers AF, Groom AC and MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2:563–572. 2002. View Article : Google Scholar : PubMed/NCBI | |
Suhail Y, Cain MP, Vanaja K, Kurywchak PA, Levchenko A, Kalluri R and Kshitiz: Systems biology of cancer metastasis. Cell Syst. 9:109–127. 2019. View Article : Google Scholar : PubMed/NCBI | |
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al: Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI | |
Mou Y, Wang J, Wu J, He D, Zhang C, Duan C and Li B: Ferroptosis, a new form of cell death: Opportunities and challenges in cancer. J Hematol Oncol. 12:342019. View Article : Google Scholar : PubMed/NCBI | |
Piskounova E, Agathocleous M, Murphy MM, Hu Z, Huddlestun SE, Zhao Z, Leitch AM, Johnson TM, DeBerardinis RJ and Morrison SJ: Oxidative stress inhibits distant metastasis by human melanoma cells. Nature. 527:186–191. 2015. View Article : Google Scholar : PubMed/NCBI | |
Li D and Li Y: The interaction between ferroptosis and lipid metabolism in cancer. Signal Transduct Target Ther. 5:1082020. View Article : Google Scholar : PubMed/NCBI | |
Zhang Z, Lu M, Chen C, Tong X, Li Y, Yang K, Lv H, Xu J and Qin L: Holo-lactoferrin: The link between ferroptosis and radiotherapy in triple-negative breast cancer. Theranostics. 11:3167–3182. 2021. View Article : Google Scholar : PubMed/NCBI | |
Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascón S, Hatzios SK, Kagan VE, et al: Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 171:273–285. 2017. View Article : Google Scholar : PubMed/NCBI | |
Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R, et al: The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 575:688–692. 2019. View Article : Google Scholar : PubMed/NCBI | |
Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B, Kaffenberger SD, Eaton JK, Shimada K, Aguirre AJ, et al: Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 547:453–457. 2017. View Article : Google Scholar : PubMed/NCBI | |
Tsoi J, Robert L, Paraiso K, Galvan C, Sheu KM, Lay J, Wong DJL, Atefi M, Shirazi R, Wang X, et al: Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress. Cancer Cell. 33:890–904.e5. 2018. View Article : Google Scholar : PubMed/NCBI | |
Ursini F and Maiorino M: Lipid peroxidation and ferroptosis: The role of GSH and GPx4. Free Radic Biol Med. 152:175–185. 2020. View Article : Google Scholar : PubMed/NCBI | |
Faubert B, Li KY, Cai L, Hensley CT, Kim J, Zacharias LG, Yang C, Do QN, Doucette S, Burguete D, et al: Lactate metabolism in human lung tumors. Cell. 171:358–371.e9. 2017. View Article : Google Scholar : PubMed/NCBI | |
Hui S, Ghergurovich JM, Morscher RJ, Jang C, Teng X, Lu W, Esparza LA, Reya T, Le Zhan Yanxiang, Guo J, et al: Glucose feeds the TCA cycle via circulating lactate. Nature. 551:115–118. 2017. View Article : Google Scholar : PubMed/NCBI | |
Wu M, Zhang X, Zhang W, Chiou YS, Qian W, Liu X, Zhang M, Yan H, Li S, Li T, et al: Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis. Nat Commun. 13:13712022. View Article : Google Scholar : PubMed/NCBI | |
Ohshima K and Morii E: Metabolic reprogramming of cancer cells during tumor progression and metastasis. Metabolites. 11:282021. View Article : Google Scholar : PubMed/NCBI | |
Icard P, Shulman S, Farhat D, Steyaert JM, Alifano M and Lincet H: How the Warburg effect supports aggressiveness and drug resistance of cancer cells? Drug Resist Updat. 38:1–11. 2018. View Article : Google Scholar : PubMed/NCBI | |
Brooks GA: The science and translation of lactate shuttle theory. Cell Metab. 27:757–785. 2018. View Article : Google Scholar : PubMed/NCBI | |
Payen VL, Mina E, Van Hée VF, Porporato PE and Sonveaux P: Monocarboxylate transporters in cancer. Mol Metab. 33:48–66. 2020. View Article : Google Scholar : | |
Pucino V, Certo M, Bulusu V, Cucchi D, Goldmann K, Pontarini E, Haas R, Smith J, Headland SE, Blighe K, et al: Lactate buildup at the site of chronic inflammation promotes disease by inducing CD4+ T cell metabolic rewiring. Cell Metab. 30:1055–1074.e8. 2019. View Article : Google Scholar | |
Pisarsky L, Bill R, Fagiani E, Dimeloe S, Goosen RW, Hagmann J, Hess C and Christofori G: Targeting metabolic symbiosis to overcome resistance to anti-angiogenic therapy. Cell Rep. 15:1161–1174. 2016. View Article : Google Scholar : PubMed/NCBI | |
García-Cañaveras JC, Chen L and Rabinowitz JD: The tumor metabolic microenvironment: Lessons from lactate. Cancer Res. 79:3155–3162. 2019. View Article : Google Scholar : PubMed/NCBI | |
Tasdogan A, Faubert B, Ramesh V, Ubellacker JM, Shen B, Solmonson A, Murphy MM, Gu Z, Gu W, Martin M, et al: Metabolic heterogeneity confers differences in melanoma metastatic potential. Nature. 577:115–120. 2020. View Article : Google Scholar | |
Zhang G, Zhang Y, Dong D, Wang F, Ma X, Guan F and Sun L: MCT1 regulates aggressive and metabolic phenotypes in bladder cancer. J Cancer. 9:2492–2501. 2018. View Article : Google Scholar : PubMed/NCBI | |
Felmlee MA, Jones RS, Rodriguez-Cruz V, Follman KE and Morris ME: Monocarboxylate transporters (SLC16): Function, regulation, and role in health and disease. Pharmacol Rev. 72:466–485. 2020. View Article : Google Scholar : PubMed/NCBI | |
Rabinowitz JD and Enerbäck S: Lactate: The ugly duckling of energy metabolism. Nat Metab. 2:566–571. 2020. View Article : Google Scholar : PubMed/NCBI | |
Gao HJ, Zhao MC, Zhang YJ, Zhou DS, Xu L, Li GB, Chen MS and Liu J: Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration. J Cancer Res Clin Oncol. 141:1151–1162. 2015. View Article : Google Scholar | |
Wang Y, Li Y, Jiang L, Ren X, Cheng B and Xia J: Prognostic value of glycolysis markers in head and neck squamous cell carcinoma: A meta-analysis. Aging (Albany NY). 13:7284–7299. 2021. View Article : Google Scholar | |
Pertega-Gomes N, Felisbino S, Massie CE, Vizcaino JR, Coelho R, Sandi C, Simoes-Sousa S, Jurmeister S, Ramos-Montoya A, Asim M, et al: A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: A role for monocarboxylate transporters as metabolic targets for therapy. J Pathol. 236:517–530. 2015. View Article : Google Scholar : PubMed/NCBI | |
Wilde L, Roche M, Domingo-Vidal M, Tanson K, Philp N, Curry J and Martinez-Outschoorn U: Metabolic coupling and the reverse Warburg effect in cancer: Implications for novel biomarker and anticancer agent development. Semin Oncol. 44:198–203. 2017. View Article : Google Scholar : PubMed/NCBI | |
Huhta H, Helminen O, Palomäki S, Kauppila JH, Saarnio J, Lehenkari PP and Karttunen TJ: Intratumoral lactate metabolism in Barrett's esophagus and adenocarcinoma. Oncotarget. 8:228942017. View Article : Google Scholar : PubMed/NCBI | |
Hu Y and Zeng F: Expressions of GPR81, MCT1 and MCT4 in squamous carcinoma and their clinical significance. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 43:950–956. 2018.In Chinese. PubMed/NCBI | |
Nakayama Y, Torigoe T, Inoue Y, Minagawa N, Izumi H, Kohno K and Yamaguchi K: Prognostic significance of monocarboxylate transporter 4 expression in patients with colorectal cancer. Exp Ther Med. 3:25–30. 2012. View Article : Google Scholar : PubMed/NCBI | |
Hubert CG, Rivera M, Spangler LC, Wu Q, Mack SC, Prager BC, Couce M, McLendon RE, Sloan AE and Rich JN: A three-dimensional organoid culture system derived from human glioblastomas recapitulates the hypoxic gradients and cancer stem cell heterogeneity of tumors found in vivo. Cancer Res. 76:2465–2477. 2016. View Article : Google Scholar : PubMed/NCBI | |
Post Y, Puschhof J, Beumer J, Kerkkamp HM, de Bakker MA, Slagboom J, de Barbanson B, Wevers NR, Spijkers XM, Olivier T, et al: Snake venom gland organoids. Cell. 180:233–247.e21. 2020. View Article : Google Scholar : PubMed/NCBI | |
Boretto M, Maenhoudt N, Luo X, Hennes A, Boeckx B, Bui B, Heremans R, Perneel L, Kobayashi H, Van Zundert I, et al: Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening. Nat Cell Biol. 21:1041–1051. 2019. View Article : Google Scholar : PubMed/NCBI | |
Haider N, Dutt P, van de Kooij B, Ho J, Palomero L, Pujana MA, Yaffe M and Stambolic V: NEK10 tyrosine phosphorylates p53 and controls its transcriptional activity. Oncogene. 39:5252–5266. 2020. View Article : Google Scholar : PubMed/NCBI | |
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar | |
Park E and Chung SW: ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation. Cell Death Dis. 10:8222019. View Article : Google Scholar : PubMed/NCBI | |
Ding CC, Rose J, Sun T, Wu J, Chen PH, Lin CC, Yang WH, Chen KY, Lee H, Xu E, et al: MESH1 is a cytosolic NADPH phosphatase that regulates ferroptosis. Nat Metab. 2:270–277. 2020. View Article : Google Scholar : PubMed/NCBI | |
Zheng J and Conrad M: The metabolic underpinnings of ferroptosis. Cell Metab. 32:920–937. 2020. View Article : Google Scholar : PubMed/NCBI | |
Dagogo-Jack I and Shaw AT: Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 15:81–94. 2018. View Article : Google Scholar | |
Burrell RA, McGranahan N, Bartek J and Swanton C: The causes and consequences of genetic heterogeneity in cancer evolution. Nature. 501:338–345. 2013. View Article : Google Scholar : PubMed/NCBI | |
Zheng H, Pomyen Y, Hernandez MO, Li C, Livak F, Tang W, Dang H, Greten TF, Davis JL, Zhao Y, et al: Single-cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma. Hepatology. 68:127–140. 2018. View Article : Google Scholar : PubMed/NCBI | |
Wang DC and Wang X: Systems heterogeneity: An integrative way to understand cancer heterogeneity. Semin Cell Dev Biol. 64:1–4. 2017. View Article : Google Scholar | |
Hitomi M, Chumakova AP, Silver DJ, Knudsen AM, Pontius WD, Murphy S, Anand N, Kristensen BW and Lathia JD: Asymmetric cell division promotes therapeutic resistance in glioblastoma stem cells. JCI Insight. 6:e1305102021. View Article : Google Scholar : | |
Marjanovic ND, Weinberg RA and Chaffer CL: Cell plasticity and heterogeneity in cancer. Clin Chem. 59:168–179. 2013. View Article : Google Scholar | |
Gerlach C, Rohr JC, Perié L, van Rooij N, van Heijst JW, Velds A, Urbanus J, Naik SH, Jacobs H, Beltman JB, et al: Heterogeneous differentiation patterns of individual CD8+ T cells. Science. 340:635–639. 2013. View Article : Google Scholar : PubMed/NCBI | |
Bergers G and Fendt SM: The metabolism of cancer cells during metastasis. Nat Rev Cancer. 21:162–180. 2021. View Article : Google Scholar : PubMed/NCBI | |
Yu L, Chen X, Wang L and Chen S: The sweet trap in tumors: Aerobic glycolysis and potential targets for therapy. Oncotarget. 7:38908–38926. 2016. View Article : Google Scholar : PubMed/NCBI | |
Brisson L, Bański P, Sboarina M, Dethier C, Danhier P, Fontenille MJ, Van Hée VF, Vazeille T, Tardy M, Falces J, et al: Lactate dehydrogenase B controls lysosome activity and autophagy in cancer. Cancer Cell. 30:418–431. 2016. View Article : Google Scholar : PubMed/NCBI | |
Kennedy KM, Scarbrough PM, Ribeiro A, Richardson R, Yuan H, Sonveaux P, Landon CD, Chi JT, Pizzo S, Schroeder T and Dewhirst MW: Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer. PLoS One. 8:e751542013. View Article : Google Scholar : PubMed/NCBI | |
Silva A, Antunes B, Batista A, Pinto-Ribeiro F, Baltazar F and Afonso J: In vivo anticancer activity of AZD3965: A systematic review. Molecules. 27:1812021. View Article : Google Scholar | |
Polański R, Hodgkinson CL, Fusi A, Nonaka D, Priest L, Kelly P, Trapani F, Bishop PW, White A, Critchlow SE, et al: Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer. Clin Cancer Res. 20:926–937. 2014. View Article : Google Scholar | |
Benyahia Z, Blackman MC, Hamelin L, Zampieri LX, Capeloa T, Bedin ML, Vazeille T, Schakman O and Sonveaux P: In vitro and in vivo characterization of MCT1 inhibitor AZD3965 confirms preclinical safety compatible with breast cancer treatment. Cancers (Basel). 13. pp. 5692021, View Article : Google Scholar | |
Beloueche-Babari M, Wantuch S, Casals Galobart T, Koniordou M, Parkes HG, Arunan V, Chung YL, Eykyn TR, Smith PD and Leach MO: MCT1 inhibitor AZD3965 increases mitochondrial metabolism, facilitating combination therapy and noninvasive magnetic resonance spectroscopy. Cancer Res. 77:5913–5924. 2017. View Article : Google Scholar : PubMed/NCBI | |
Wang G, Wang JJ, Yin PH, Xu K, Wang YZ, Shi F, Gao J and Fu XL: New strategies for targeting glucose metabolism-mediated acidosis for colorectal cancer therapy. J Cell Physiol. 234:348–368. 2018. View Article : Google Scholar : PubMed/NCBI | |
Fan J, Ye J, Kamphorst JJ, Shlomi T, Thompson CB and Rabinowitz JD: Quantitative flux analysis reveals folate-dependent NADPH production. Nature. 510:298–302. 2014. View Article : Google Scholar : PubMed/NCBI | |
Pavlova NN and Thompson CB: The emerging hallmarks of cancer metabolism. Cell Metab. 23:27–47. 2016. View Article : Google Scholar : PubMed/NCBI | |
Lewis C A, Parker SJ, Fiske BP, McCloskey D, Gui D Y, Green CR, Vokes NI, Feist AM, Vander Heiden MG and Metallo CM: Tracing compartmentalized NADPH metabolism in the cytosol and mitochondria of mammalian cells. Mol Cell. 55:253–263. 2014. View Article : Google Scholar : PubMed/NCBI | |
Wang X, Liu Z, Sun J, Song X, Bian M, Wang F, Yan F and Yu Z: Inhibition of NADPH oxidase 4 attenuates lymphangiogenesis and tumor metastasis in breast cancer. FASEB J. 35:e215312021.PubMed/NCBI | |
Lu YX, Ju HQ, Liu ZX, Chen DL, Wang Y, Zhao Q, Wu QN, Zeng ZL, Qiu HB, Hu PS, et al: ME1 regulates NADPH homeostasis to promote gastric cancer growth and metastasis. Cancer Res. 78:1972–1985. 2018. View Article : Google Scholar : PubMed/NCBI | |
Tamošiūnas M, Plorina EV, Lange M, Derjabo A, Kuzmina I, Bļizņuks D and Spigulis J: Autofluorescence imaging for recurrence detection in skin cancer postoperative scars. J Biophotonics. 13:e2019001622020. View Article : Google Scholar | |
Huang TT, Chen KC, Wong TY, Chen CY, Chen WC, Chen YC, Chang MH, Wu DY, Huang TY, Nioka S, et al: Two-channel auto-fluorescence analysis for oral cancer. J Biomed Opt. 24:1–10. 2018. View Article : Google Scholar : PubMed/NCBI | |
Gulali A, Mustafa S, Ibrahim K, Erkus E, Ozer B, Kocak MZ, Yaman S, Keyif F, Altinordu R, Erkol H and Savli H: Could red cell distribution width be a marker of thyroid cancer? J Coll Physicians Surg Pak. 27:556–558. 2017. | |
Chamma E, Qiu J, Lindvere-Teene L, Blackmore KM, Majeed S, Weersink R, Dickie CI, Griffin AM, Wunder JS, Ferguson PC and DaCosta RS: Optically-tracked handheld fluorescence imaging platform for monitoring skin response in the management of soft tissue sarcoma. J Biomed Opt. 20:0760112015. View Article : Google Scholar : PubMed/NCBI | |
Waaijer L, Filipe MD, Simons J, van der Pol CC, de Boorder T, van Diest PJ and Witkamp AJ: Detection of breast cancer precursor lesions by autofluorescence ductoscopy. Breast Cancer. 28:119–129. 2021. View Article : Google Scholar | |
Borile G, Sandrin D, Filippi A, Anderson KI and Romanato F: Label-free multiphoton microscopy: Much more than fancy images. Int J Mol Sci. 22:26572021. View Article : Google Scholar : PubMed/NCBI | |
Salvagno GL, Sanchis-Gomar F, Picanza A and Lippi G: Red blood cell distribution width: A simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci. 52:86–105. 2015. View Article : Google Scholar | |
Ma W, Mao S, Bao M, Wu Y, Guo Y, Liu J, Wang R, Li C, Zhang J, Zhang W and Yao X: Prognostic significance of red cell distribution width in bladder cancer. Transl Androl Urol. 9:295–302. 2020. View Article : Google Scholar : PubMed/NCBI | |
Wang PF, Song SY, Guo H, Wang TJ, Liu N and Yan CX: Prognostic role of pretreatment red blood cell distribution width in patients with cancer: A meta-analysis of 49 studies. J Cancer. 10:43052019. View Article : Google Scholar : PubMed/NCBI | |
Han F, Liu Y, Cheng S, Sun Z, Sheng C, Sun X, Shang X, Tian W, Wang X, Li J, et al: Diagnosis and survival values of neutrophil-lymphocyte ratio (NLR) and red blood cell distribution width (RDW) in esophageal cancer. Clin Chim Acta. 488:150–158. 2019. View Article : Google Scholar | |
Ghosh M, Saha S, Bettke J, Nagar R, Parrales A, Iwakuma T, van der Velden AWM and Martinez LA: Mutant p53 suppresses innate immune signaling to promote tumorigenesis. Cancer Cell. 39:494–508.e5. 2021. View Article : Google Scholar : PubMed/NCBI | |
Watson MJ, Vignali PDA, Mullett SJ, Overacre-Delgoffe AE, Peralta RM, Grebinoski S, Menk AV, Rittenhouse NL, DePeaux K, Whetstone RD, et al: Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature. 591:645–651. 2021. View Article : Google Scholar : PubMed/NCBI | |
Karsten E, Breen E, McCracken SA, Clarke S and Herbert BR: Red blood cells exposed to cancer cells in culture have altered cytokine profiles and immune function. Sci Rep. 10:77272020. View Article : Google Scholar : PubMed/NCBI | |
Li ZX, Zheng ZQ, Wei ZH, Zhang LL, Li F, Lin L, Liu RQ, Huang XD, Lv JW, Chen FP, et al: Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment. Theranostics. 9:7648–7665. 2019. View Article : Google Scholar : PubMed/NCBI | |
Diakos CI, Charles KA, McMillan DC and Clarke SJ: Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 15:e493–e503. 2014. View Article : Google Scholar : PubMed/NCBI | |
Duan Q, Zhang H, Zheng J and Zhang L: Turning cold into hot: Firing up the tumor microenvironment. Trends Cancer. 6:605–618. 2020. View Article : Google Scholar : PubMed/NCBI | |
Hou J, Karin M and Sun B: Targeting cancer-promoting inflammation-have anti-inflammatory therapies come of age? Nat Rev Clin Oncol. 18:261–279. 2021. View Article : Google Scholar : PubMed/NCBI | |
Yu Y, Yan Y, Niu F, Wang Y, Chen X, Su G, Liu Y, Zhao X, Qian L, Liu P and Xiong Y: Ferroptosis: A cell death connecting oxidative stress, inflammation and cardiovascular diseases. Cell Death Discov. 7:1932021. View Article : Google Scholar : PubMed/NCBI | |
Meacham CE and Morrison SJ: Tumour heterogeneity and cancer cell plasticity. Nature. 501:328–337. 2013. View Article : Google Scholar : PubMed/NCBI | |
Boumahdi S and de Sauvage FJ: The great escape: Tumour cell plasticity in resistance to targeted therapy. Nat Rev Drug Discov. 19:39–56. 2020. View Article : Google Scholar | |
Zhou B, Zhang JY, Liu XS, Chen HZ, Ai YL, Cheng K, Sun RY, Zhou D, Han J and Wu Q: Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis. Cell Res. 28:1171–1185. 2018. View Article : Google Scholar : PubMed/NCBI | |
Ubellacker JM, Tasdogan A, Ramesh V, Shen B, Mitchell EC, Martin-Sandoval MS, Gu Z, McCormick ML, Durham AB, Spitz DR, et al: Lymph protects metastasizing melanoma cells from ferroptosis. Nature. 585:113–118. 2020. View Article : Google Scholar : PubMed/NCBI |